Board of Trustees of The Leland Stanford Junior University’s Bolt Biotherapeutics BOLT Stock Holding History

Board of Trustees of The Leland Stanford Junior University’s Portfolio BOLT Stock Details BOLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$139K	Hold	35,977	–	–	0.03%	17
2026 Q1	$145K	Hold	35,977	–	–	0.02%	18
2025 Q4	$197K	Sell	35,977 -1	-0%	-$5	0.04%	17
2025 Q3	$191K	Hold	35,978	–	–	0.02%	18
2025 Q2	$208K	Buy	35,978 +1	+0%	+$7	0.02%	19
2025 Q1	$288K	Hold	35,977	–	–	0.02%	18
2024 Q4	$385K	Hold	35,977	–	–	0.03%	18
2024 Q3	$466K	Hold	35,977	–	–	0.04%	17
2024 Q2	$540K	Hold	35,977	–	–	0.04%	18
2024 Q1	$1.01M	Hold	35,977	–	–	0.09%	14
2023 Q4	$806K	Sell	35,977 -1,878	-5%	-$36.6K	0.05%	23
2023 Q3	$787K	Buy	37,855 +1,878	+5%	+$45.9K	0.06%	16
2023 Q2	$921K	Hold	35,977	–	–	0.09%	20
2023 Q1	$1M	Hold	35,977	–	–	0.09%	23
2022 Q4	$936K	Hold	35,977	–	–	0.1%	21
2022 Q3	$1.06M	Hold	35,977	–	–	0.07%	32
2022 Q2	$1.47M	Hold	35,977	–	–	0.1%	20
2022 Q1	$1.97M	Hold	35,977	–	–	0.11%	19
2021 Q4	$3.53M	Hold	35,977	–	–	0.22%	18
2021 Q3	$9.1M	Hold	35,977	–	–	0.68%	13
2021 Q2	$11.1M	Buy	+35,977	New	+$14.6M	1.04%	13

Other funds holding BOLT

T3 Companies New York $93.7M AUM

LCM

Lynx1 Capital Management San Juan, Puerto Rico $508M AUM 163.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $80B AUM 26.12% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Board of Trustees of The Leland Stanford Junior University's BOLT Position: Q2 2026 in Review

Board of Trustees of The Leland Stanford Junior University held its Bolt Biotherapeutics (BOLT) position steady in Q2 2026 at 35,977 shares worth $139K. The position accounts for 0.03% of the portfolio, ranked #17.

Board of Trustees of The Leland Stanford Junior University first reported a position in BOLT in Q2 2021 and has held it in 21 quarters since. The position peaked at $11.1M in Q2 2021. 11 funds tracked by Wall St. Rank hold BOLT as of Q2 2026.

Board of Trustees of The Leland Stanford Junior University held 35,977 shares of Bolt Biotherapeutics worth $139K as of Q2 2026.
Board of Trustees of The Leland Stanford Junior University left its Bolt Biotherapeutics share count unchanged in Q2 2026.
Bolt Biotherapeutics made up 0.03% of Board of Trustees of The Leland Stanford Junior University's portfolio in Q2 2026, its #17 holding.
Board of Trustees of The Leland Stanford Junior University first reported a position in Bolt Biotherapeutics in Q2 2021 and has held it in 21 quarters since.
Board of Trustees of The Leland Stanford Junior University's Bolt Biotherapeutics position peaked at $11.1M in Q2 2021.
11 funds tracked by Wall St. Rank held Bolt Biotherapeutics as of Q2 2026.

Based on Board of Trustees of The Leland Stanford Junior University's 13F filing for Q2 2026, filed 12 Aug 2026.